046sek
0,2 %
Date:2026-07-08Time:15:13:22Latest report:Q1-2026List:Small CapTicker:NICA
Market Cap:153 msekEnterprise Value:232 msekNet Sales:31,8 msekEarnings:25,1 msekEmployees:0ISIN:SE0005454873

Ratios

10-year key figure history for Nanologica turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanologica with index and moving average MA50 and MA200.

Stockprice:0,46
MA50:0,55
MA200:0,72
Price/MA200:-35,8 %
RSI (14):36,5
Price/MA50:-16,2 %

Description

Nanologica is a life science tools company that develops, manufactures and sells advanced input products to pharmaceutical companies. Nanologica's silica-based products are specifically designed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Nanologica operates in a global niche market for drugs for the treatment of diabetes and obesity. Nanologica was founded in 2004 and is headquartered in Södertälje.

Biotechnology